Prognostic Factors and Primary Treatment for Waldenström Macroglobulinemia - A Swedish Lymphoma Registry Study

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15558
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Waldenström Macroglobulinemia

2020English

Prognostic Factors and Indications for Treatment of Waldenström's Macroglobulinemia

Best Practice and Research in Clinical Haematology
OncologyClinical Biochemistry
2016English

Treatment Strategies and Prognostic Factors of Primary Gastric Diffuse Large B Cell Lymphoma: A Retrospective Study of 303 Cases From China Lymphoma Patient Registry

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

A 50-Year-Long Study of Waldenström Macroglobulinemia

Mayo Clinic Proceedings
Medicine
2019English

Treatment Strategies and Prognostic Factors of Primary Gastric Diffuse Large B Cell Lymphoma: A Retrospective Multicenter Study of 272 Cases From the China Lymphoma Patient Registry

International Journal of Medical Sciences
Medicine
2019English

Familial Aggregation of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia With Solid Tumors and Myeloid Malignancies

Acta Haematologica
MedicineHematology
2012English

Waldenström Macroglobulinemia: Review of Pathogenesis and Management

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2017English

CNS Vasculitis Associated With Waldenström Macroglobulinemia

Case Reports in Neurological Medicine
2016English

The Bone Marrow Microenvironment in Waldenström Macroglobulinemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy